Study to Evaluate Injection Pain and Local Tolerability Following Administration of TV-46046
- Study Title
- A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous Administration of TV-46046
- Teva Identifier
- TV46046-WH-10147
- ClinicalTrials.gov Identifier
- NCT03700658
- Study Status
- Completed
- Trial Condition(s)
- Contraception
- Interventions
- Drug: TV-46046 - 1 | Drug: TV-46046 - 2 | Drug: medroxyprogesterone acetate injectable suspension | Drug: TV-46046 Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 50 Years
- Trial Duration
- December 14, 2018 - October 2, 2020
- Phase
- Phase 1
